On January 16, 2026, the Rosen Law Firm announced it is investigating potential securities claims on behalf of Trip.com Group Limited shareholders. The firm alleges that Trip.com may have issued materially misleading information when disclosing the regulatory scrutiny by China’s market regulator. Investors who purchased American Depositary Shares have been notified that they may recover losses through a contingency fee arrangement. The Rosen Law Firm highlights its track record, including the largest ever securities class action settlement against a Chinese company, recovering over $438 million for investors in 2019 and maintaining a top-4 ISS ranking since 2013.

On January 14, 2026, China’s State Administration for Market Regulation launched an investigation into Trip.com’s hotel-booking operations, citing potential anti-competitive practices. Trip.com controls over 60% of the domestic online travel market through direct operations and strategic stakes in rivals. Following the announcement, the company’s ADS declined by 17% in a single session, and over the subsequent four trading days its share price fell by 22%. Authorities may impose significant fines, require divestitures of interests in Tongcheng and Qunar, and prohibit exclusivity agreements with hotel partners.

A cohort of buy-side hedge professionals argues that the regulatory sell-off presents a buying opportunity. They note that historical antitrust actions in China have typically resulted in fines without lasting disruption to core operations. Under a conservative scenario, even a substantial penalty leaves the stock trading at a reasonable 2026 price-earnings multiple, supported by double-digit revenue growth forecasts, robust cash generation, and upside from outbound travel demand and major global events. Analysts highlight the secular shift toward experiential spending and Trip.com’s expansion among younger demographics as long-term catalysts.